Skip to main content
. 2020 Nov 13;99(46):e23249. doi: 10.1097/MD.0000000000023249

Table 3.

Drugs used for the patients under oral therapy.

Characteristic Number (%) (n = 37)
Levodopa-Carbidopa 36 (100.00)
MAO-B Inhibitors 20 (55.56)
Dopaminergic Agonists 15 (41.67)
Anticholinergic Agents 2 (5.56)
Amantadine 7 (19.44)
COMT inhibitor (Entcapone) 4/35 (11.43)